WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers

Wild-type Wilms' tumor gene WT1 is expressed at a high level in hematopoietic malignancies including acute leukemia, chronic myelogenous leukemia, and myelodysplastic syndromes, as well as in various kinds of solid cancers. Human cytotoxic T lymphocytes (CTLs), which could specifically lyse WT1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ScientificWorldJournal
Autors principals: Oka, Yoshihiro, Tsuboi, Akihiro, Elisseeva, Olga A., Nakajima, Hiroko, Fujiki, Fumihiro, Kawakami, Manabu, Shirakata, Toshiaki, Nishida, Sumiyuki, Hosen, Naoki, Oji, Yusuke, Kawase, Ichiro, Sugiyama, Haruo
Format: Artigo
Idioma:Inglês
Publicat: TheScientificWorldJOURNAL 2007
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5901323/
https://ncbi.nlm.nih.gov/pubmed/17619750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2007.119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars